Citigroup’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$726K Sell
642,542
-45,982
-7% -$52K ﹤0.01% 2702
2025
Q1
$1.01M Sell
688,524
-27,712
-4% -$40.5K ﹤0.01% 2551
2024
Q4
$1.53M Buy
716,236
+246,926
+53% +$526K ﹤0.01% 2303
2024
Q3
$1.31M Buy
469,310
+394,138
+524% +$1.1M ﹤0.01% 2357
2024
Q2
$175K Sell
75,172
-603,057
-89% -$1.41M ﹤0.01% 3238
2024
Q1
$3.03M Buy
678,229
+643,905
+1,876% +$2.88M ﹤0.01% 1539
2023
Q4
$110K Sell
34,324
-304,432
-90% -$977K ﹤0.01% 3426
2023
Q3
$1.07M Buy
338,756
+57,392
+20% +$182K ﹤0.01% 1851
2023
Q2
$1.4M Sell
281,364
-273,979
-49% -$1.36M ﹤0.01% 1979
2023
Q1
$2.74M Buy
555,343
+210,972
+61% +$1.04M ﹤0.01% 1366
2022
Q4
$2.17M Sell
344,371
-113,418
-25% -$713K ﹤0.01% 1467
2022
Q3
$4.94M Buy
457,789
+216,824
+90% +$2.34M ﹤0.01% 1140
2022
Q2
$2.75M Buy
240,965
+121,800
+102% +$1.39M ﹤0.01% 1397
2022
Q1
$1.09M Sell
119,165
-146,219
-55% -$1.33M ﹤0.01% 2266
2021
Q4
$3.96M Buy
265,384
+138,729
+110% +$2.07M ﹤0.01% 1434
2021
Q3
$3.26M Sell
126,655
-71,633
-36% -$1.84M ﹤0.01% 1540
2021
Q2
$5.17M Buy
198,288
+74,327
+60% +$1.94M ﹤0.01% 1392
2021
Q1
$4.38M Buy
123,961
+101,390
+449% +$3.58M ﹤0.01% 1418
2020
Q4
$570K Buy
22,571
+11,806
+110% +$298K ﹤0.01% 2546
2020
Q3
$406K Sell
10,765
-39,105
-78% -$1.47M ﹤0.01% 2370
2020
Q2
$2.14M Buy
49,870
+4,254
+9% +$182K ﹤0.01% 1582
2020
Q1
$887K Buy
45,616
+504
+1% +$9.8K ﹤0.01% 1897
2019
Q4
$1.17M Buy
45,112
+2,733
+6% +$71K ﹤0.01% 2080
2019
Q3
$1.16M Sell
42,379
-50,790
-55% -$1.38M ﹤0.01% 2017
2019
Q2
$2.5M Buy
93,169
+89,284
+2,298% +$2.4M ﹤0.01% 1485
2019
Q1
$112K Sell
3,885
-1,747
-31% -$50.4K ﹤0.01% 3493
2018
Q4
$152K Buy
+5,632
New +$152K ﹤0.01% 3253